Precision medicine

An analysis of 1,000 Swedish genomes reveals greater heterogeneity and shows why the human reference genome needs updating

Pharmacogenomic testing can only improve patient care if it’s clinically validated, judiciously applied, and easily understood by healthcare providers

A new genomic barcode tracker could help spot the rare immune cells that are most effective against cancer

The combination of genome-scale CRISPR experiments and powerful computational approaches has created a Cancer Dependency Map

Kidney discard rates are higher than ever – but the procurement biopsies that often rule out their use are unreliable and need to be standardized

Higher tumor mutational burden is linked to improved survival across multiple cancer types.

Simultaneous multiplex immunohistochemistry can provide efficient testing of multiple targets when diagnosing and selecting treatment for cancer

A response to David Rimm’s letter that supports the role of PD-L1 testing in improving outcomes for cancer patients.

David Rimm challenges the sensitivity and reproducibility of a new assay for PD-L1 detection.

Techniques like droplet digital PCR technology can assist with early monitoring of cancer immunotherapy to ensure the right treatment for each patient